Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma

Cited 5 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorJi Yong Yoon-
dc.contributor.authorJeong Ju Lee-
dc.contributor.authorS Gu-
dc.contributor.authorM E Jung-
dc.contributor.authorHyun Soo Cho-
dc.contributor.authorJung Hwa Lim-
dc.contributor.authorSoo Young Jun-
dc.contributor.authorJun Ho Ahn-
dc.contributor.authorJu-Sik Min-
dc.contributor.authorMin Hyuk Choi-
dc.contributor.authorSu Jin Jeon-
dc.contributor.authorYong Jae Lee-
dc.contributor.authorA Go-
dc.contributor.authorY J Heo-
dc.contributor.authorCho Rok Jung-
dc.contributor.authorG Choi-
dc.contributor.authorK Lee-
dc.contributor.authorM K Jeon-
dc.contributor.authorNam-Soon Kim-
dc.date.accessioned2018-04-19T05:18:28Z-
dc.date.available2018-04-19T05:18:28Z-
dc.date.issued2017-
dc.identifier.issn19492553-
dc.identifier.uri10.18632/oncotarget.22614ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/17627-
dc.description.abstractHepatocellular carcinoma (HCC) is one of the most malignant tumors. Although various treatments, such as surgery and chemotherapy, have been developed, a novel alternative therapeutic approach for HCC therapy is urgently needed. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) is a promising anti-cancer agent, but many cancer cells are resistant to TRAIL-induced apoptosis. To help overcome TRAIL resistance in HCC cancer cells, we have identified novel chemical compounds that act as TRAIL sensitizers. We first identified the hit compound, TRT-0002, from a chemical library of 6,000 compounds using a previously developed high-throughput enzymelinked immunosorbent assay (ELISA) screening system, which was based on the interaction of mitogen-activated protein kinase kinase 7 (MKK7) and TOR signaling pathway regulator-like (TIPRL) proteins and a cell viability assay. To increase the efficacy of this TRAIL sensitizer, we synthesized 280 analogs of TRT-0002 and finally identified two lead compounds (TRT-0029 and TRT-0173). Co-treating cultured Huh7 cells with either TRT-0029 or TRT-0173 and TRAIL resulted in TRAIL-induced apoptosis due to the inhibition of the MKK7-TIPRL interaction and subsequent phosphorylation of MKK7 and c-Jun N-terminal kinase (JNK). In vivo, injection of these compounds and TRAIL into HCC xenograft tumors resulted in tumor regression. Taken together, our results suggest that the identified lead compounds serve as TRAIL sensitizers and represent a novel strategy to overcome TRAIL resistance in HCC.-
dc.publisherImpact Journalsko
dc.titleNovel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma-
dc.title.alternativeNovel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma-
dc.typeArticle-
dc.citation.titleOncotarget-
dc.citation.number68-
dc.citation.endPage112622-
dc.citation.startPage112610-
dc.citation.volume8-
dc.contributor.affiliatedAuthorJi Yong Yoon-
dc.contributor.affiliatedAuthorJeong Ju Lee-
dc.contributor.affiliatedAuthorHyun Soo Cho-
dc.contributor.affiliatedAuthorJung Hwa Lim-
dc.contributor.affiliatedAuthorYong Jae Lee-
dc.contributor.affiliatedAuthorCho Rok Jung-
dc.contributor.affiliatedAuthorNam-Soon Kim-
dc.contributor.alternativeName윤지용-
dc.contributor.alternativeName이정주-
dc.contributor.alternativeName구수진-
dc.contributor.alternativeName정명은-
dc.contributor.alternativeName조현수-
dc.contributor.alternativeName임정화-
dc.contributor.alternativeName전수영-
dc.contributor.alternativeName안준호-
dc.contributor.alternativeName민주식-
dc.contributor.alternativeName최민혁-
dc.contributor.alternativeName전수진-
dc.contributor.alternativeName이용재-
dc.contributor.alternativeName고아름-
dc.contributor.alternativeName허윤정-
dc.contributor.alternativeName정초록-
dc.contributor.alternativeName최길돈-
dc.contributor.alternativeName이광호-
dc.contributor.alternativeName전문국-
dc.contributor.alternativeName김남순-
dc.identifier.bibliographicCitationOncotarget, vol. 8, no. 68, pp. 112610-112622-
dc.identifier.doi10.18632/oncotarget.22614-
dc.subject.keywordHCC-
dc.subject.keywordTIPRL-
dc.subject.keywordTRAIL sensitizer-
dc.subject.keywordapoptosis-
dc.subject.localHCC-
dc.subject.localTIPRL-
dc.subject.localTRAIL sensitizer-
dc.subject.localapoptosis-
dc.subject.localApoptosis-
dc.description.journalClassN-
Appears in Collections:
Division of Biomedical Research > Rare Disease Research Center > 1. Journal Articles
Division of Research on National Challenges > Stem Cell Convergenece Research Center > 1. Journal Articles
Jeonbuk Branch Institute > Biological Resource Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.